MC

Man Sung Co

GI Genetics Institute: 6 patents #56 of 327Top 20%
PL Protein Design Labs: 6 patents #2 of 31Top 7%
AC Ajinomoto Co.: 4 patents #463 of 2,190Top 25%
OI Osaka Bioscience Institute: 2 patents #12 of 57Top 25%
MC Memorial Sloan Kettering Cancer Center: 2 patents #240 of 761Top 35%
MC Mochida Pharmaceutical Co.: 2 patents #106 of 309Top 35%
PB Pdl Biopharma: 1 patents #15 of 40Top 40%
SA Sandoz Ag: 1 patents #497 of 1,103Top 50%
TL Teijin Limited: 1 patents #850 of 1,631Top 55%
📍 Cupertino, CA: #835 of 6,989 inventorsTop 15%
🗺 California: #28,827 of 386,348 inventorsTop 8%
Overall (All Time): #225,257 of 4,157,543Top 6%
20
Patents All Time

Issued Patents All Time

Showing 1–20 of 20 patents

Patent #TitleCo-InventorsDate
7846435 Humanized antibodies that recognize Verotoxin II and cell line producing same Yoh-ichi Matsumoto, Atsuchi Imaizumi, Tsuyoshi Kimura, Tae Takeda, Maximiliano Vasquez 2010-12-07
7666421 Methods of treatment of autoimmune diseases using humanized immunoglobulin reactive with B7-2 Maximiliano Vasquez, Beatriz Carreno, Abbie Cheryl Celniker, Mary Collins, Samuel Goldman +5 more 2010-02-23
7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules Maximiliano Vasquez, Beatriz Carreno, Abbie Cheryl Celniker, Mary Collins, Samuel Goldman +5 more 2009-05-12
7311913 Methods of treating thrombotic diseases with von Willebrand factor specific antibodies Maximiliano Vasquez 2007-12-25
7138116 Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody Maximiliano Vasquez 2006-11-21
6984383 Method of transplanting cells by contacting donor cells with B7-1-and B7-2-specific immunoglobulins Maximiliano Vasquez, Beatriz Carreno, Abbie Cheryl Celniker, Mary Collins, Samuel Goldman +5 more 2006-01-10
6972125 Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith Maximiliano Vasquez, Beatriz Carreno, Abbie Cheryl Celniker, Mary Collins, Samuel Goldman +5 more 2005-12-06
6933368 Increasing antibody affinity by altering glycosylation of immunoglobulin variable region David A. Scheinberg, Cary L. Queen 2005-08-23
6913747 Humanized immunoglobulin reactive with B7 therewith Maximiliano Vasquez, Beatriz Carreno, Abbie Cheryl Celniker, Mary Collins, Samuel Goldman +5 more 2005-07-05
6827934 Humanized immunoglobulin reactive with b7-2 and methods of treatment therewith Maximiliano Vasquez, Beatriz Carreno, Abbie Cheryl Celniker, Mary Collins, Samuel Goldman +5 more 2004-12-07
6613328 Methods of treating thrombotic diseases with von Willebrand factor specific antibodies Maximiliano Vasquez 2003-09-02
6350861 Antibodies with increased binding affinity David A. Scheinberg, Cary L. Queen 2002-02-26
6228360 Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody Maximiliano Vasquez 2001-05-08
6210671 Humanized antibodies reactive with L-selectin 2001-04-03
6114507 Anti-Fas ligand antibody and assay method using the anti-Fas ligand antibody Kamon Shirakawa, Tomokazu Matsusue, Shigekazu Nagata, Maximiliano Vasquez 2000-09-05
6096312 Agent for suppressing a reduction of CD4.sup.+ lymphocytes Norio Nakamura, Kamon Shirakawa, Tomokazu Matsusue, Shigekazu Nagata, Maximiliano Vasquez 2000-08-01
5777085 Humanized antibodies reactive with GPIIB/IIIA J. Yun Tso 1998-07-07
5714350 Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region David A. Scheinberg, Cary L. Queen 1998-02-03
5693762 Humanized immunoglobulins Cary L. Queen, William P. Schneider, Nicholas F. Landolfi, Kathleen L. Coelingh, Harold E. Selick 1997-12-02
5562903 Humanized antibodies that recognize difucosyl Lewis blood group antigens Y-6 and B-7-2 Hans Loibner 1996-10-08